| abstract |
Compounds repre-sented by Formula (I): are useful in treating diseases, such as cancer, that are mediated and/or associated (at least in part) with AxI kinase. The compounds can be formulated as pharmaceutically acceptable compo-sitions for administration to a subject in need thereof. |